Patents · inventor
John Devane
- Patents
- 16 granted 2011-04-19 to 2026-10-20
- Places
- Athlone, IE; Dublin, IE; Roscommon, IE
- Most often assigned to
- AMNEAL PHARMACEUTICALS LLC
- Source
- PVGPATDIS, file of 2026-10-20; PatentsView inventor ID fl:jo_ln:devane-1
Patents
| Patent | Title | Granted | Assignees | Source |
|---|---|---|---|---|
| US 12768840 | Method for monitoring and preventing clinically significant ketone levels in patients receiving dichloroacetate co-administered with a carbohydrate restricted diet | 2026-10-20 | SAOL INTERNATIONAL DEVELOPMENT LTD.; UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | PTBLXML, file of 2026-10-20 |
| US 12383522 | Baclofen formulations and methods of minimizing patient exposure to metabolite variations | 2025-08-12 | AMNEAL PHARMACEUTICALS LLC | PVGPATDIS, file of 2026-04-10 |
| US 12011502 | Compositions and methods of administering baclofen | 2024-06-18 | AMNEAL PHARMACEUTICALS LLC | PVGPATDIS, file of 2026-04-10 |
| US 11931328 | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives | 2024-03-19 | AMNEAL PHARMACEUTICALS LLC | PVGPATDIS, file of 2026-04-10 |
| US 11850225 | Baclofen formulations and methods of minimizing patient exposure to metabolite variations | 2023-12-26 | AMNEAL PHARMACEUTICALS LLC | PVGPATDIS, file of 2026-04-10 |
| US 11654124 | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives | 2023-05-23 | AMNEAL PHARMACEUTICALS LLC | PVGPATDIS, file of 2026-04-10 |
| US 11523984 | Compositions and methods of administering baclofen | 2022-12-13 | AMNEAL PHARMACEUTICALS LLC | PVGPATDIS, file of 2026-04-10 |
| US 11491125 | Baclofen formulations and methods of minimizing patient exposure to metabolite variations | 2022-11-08 | AMNEAL PHARMACEUTICALS LLC | PVGPATDIS, file of 2026-04-10 |
| US 11083695 | Injectable phenol formulations and methods of manufacture | 2021-08-10 | SAOL INTERNATIONAL DEVELOPMENT LTD. | PVGPATDIS, file of 2026-04-10 |
| US 11083694 | Injectable phenol formulations and methods of their use | 2021-08-10 | SAOL INTERNATIONAL DEVELOPMENT LTD. | PVGPATDIS, file of 2026-04-10 |
| US 10959962 | Injectable phenol formulations and methods of their use | 2021-03-30 | SAOL INTERNATIONAL DEVELOPMENT LTD. | PVGPATDIS, file of 2026-04-10 |
| US 10792262 | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives | 2020-10-06 | SAOL INTERNATIONAL LIMITED | PVGPATDIS, file of 2026-04-10 |
| US 10751312 | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives | 2020-08-25 | SAOL INTERNATIONAL LIMITED | PVGPATDIS, file of 2026-04-10 |
| US 9040591 | Methods and compositions comprising at least one α3 βA4 nAChR antagonist or pharmaceutically acceptable salt thereof | 2015-05-26 | AGI Therapeutics Public Limited Company | PVGPATDIS, file of 2026-04-10 |
| US 8119163 | Nanoparticulate and controlled release compositions comprising cefditoren | 2012-02-21 | Alkermes Pharma Ireland Limited | PVGPATDIS, file of 2026-04-10 |
| US 7928092 | Formulations and methods of treating inflammatory bowel disease | 2011-04-19 | AGI Therapeutics Limited | PVGPATDIS, file of 2026-04-10 |
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. PatentsView groups an inventor’s patents by name, place and co-inventors (disambiguation); a person page link is by name and state, or name and employer.